Rapid Micro Biosystems (NASDAQ:RPID) Downgraded to “Sell” Rating by Wall Street Zen

Rapid Micro Biosystems (NASDAQ:RPID) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Sunday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Rapid Micro Biosystems presently has a consensus rating of “Moderate Buy” and an average target price of $8.00.

Rapid Micro Biosystems Trading Down 3.9%

Shares of RPID opened at $2.98 on Friday. The stock has a fifty day moving average of $3.53 and a two-hundred day moving average of $3.34. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 4.23. The company has a market capitalization of $132.07 million, a PE ratio of -2.95 and a beta of 1.33. Rapid Micro Biosystems has a fifty-two week low of $0.87 and a fifty-two week high of $4.50.

Rapid Micro Biosystems (NASDAQ:RPID) last posted its quarterly earnings data on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.26). The business had revenue of $7.84 million for the quarter, compared to analysts’ expectations of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. As a group, analysts forecast that Rapid Micro Biosystems will post -1.1 EPS for the current year.

Institutional Investors Weigh In On Rapid Micro Biosystems

Institutional investors have recently bought and sold shares of the business. American Century Companies Inc. purchased a new position in shares of Rapid Micro Biosystems in the 1st quarter valued at $31,000. OMERS ADMINISTRATION Corp acquired a new stake in Rapid Micro Biosystems in the 1st quarter valued at $289,000. ABG WTT Global Life Science Capital Partners GP Ltd raised its position in Rapid Micro Biosystems by 78.0% in the first quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company’s stock valued at $4,880,000 after purchasing an additional 810,000 shares during the period. Parkman Healthcare Partners LLC acquired a new position in shares of Rapid Micro Biosystems during the first quarter worth about $1,942,000. Finally, Geode Capital Management LLC lifted its stake in shares of Rapid Micro Biosystems by 1.6% during the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock worth $704,000 after purchasing an additional 3,143 shares in the last quarter. 52.60% of the stock is currently owned by hedge funds and other institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.